Policy Watch: 20 Regulatory Updates — March 20, 2026
This update covers drug enforcement controlled substances regulatory policy changes relevant to cannabis clinicians. It highlights new scheduling of synthetic cannabinoids and benzodiazepine analogs. Clinicians should stay informed on these regulatory…
Policy Watch: 10 Regulatory Updates — March 19, 2026
This update covers DEA synthetic opioid scheduling and regulatory changes relevant to cannabis clinicians. The focus is on new Schedule I placements and their clinical implications. These regulatory updates inform patient care and research considerations.
Policy Watch: 26 Regulatory Updates — March 08, 2026
The marijuana rescheduling proposal is a key focus in the March 2026 regulatory updates. This change could impact cannabis clinical practice and research access. Marijuana rescheduling remains central to evolving federal cannabis policy.